Ching-Chun Li
Overview
Explore the profile of Ching-Chun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuang J, Tsai H, Chen P, Huang C, Su W, Chang T, et al.
Kaohsiung J Med Sci
. 2025 Mar;
:e70008.
PMID: 40078099
Neoadjuvant chemoradiotherapy (NACRT) is the standard treatment for patients with locally advanced rectal cancer (LARC). Tumor regression grade (TRG) is an essential prognostic factor in determining treatment efficacy. However, the...
2.
Chuang J, Tsai H, Su W, Chen P, Huang C, Chang T, et al.
Oncol Res
. 2024 Oct;
32(11):1723-1732.
PMID: 39449806
The pTNM staging system is widely recognized as the most effective prognostic indicator for cancer. The latest update of this staging system introduced a new pathological staging system (ypTNM) for...
3.
Yin T, Chen Y, Su W, Chang T, Chen P, Li C, et al.
Surg Endosc
. 2024 Oct;
38(12):7621-7626.
PMID: 39433589
Background: Intracorporeal anastomosis offers notable advantages over extracorporeal techniques, including reduced tissue manipulation leading to faster recovery and potentially lower risks of surgical site infections and complications. However, it also...
4.
Tsai H, Huang C, Chen Y, Su W, Chang T, Chen P, et al.
Medicina (Kaunas)
. 2023 Dec;
59(12).
PMID: 38138211
: Approximately 5-10% of all patients with metastatic colorectal cancer (mCRC) harbor a mutation. These patients exhibit distinct metastatic patterns, poor prognosis, and heterogenous survival outcomes. The findings from the...
5.
Chen Y, Huang C, Li C, Chang T, Su W, Chen P, et al.
World J Surg Oncol
. 2023 Dec;
21(1):378.
PMID: 38041083
Background: Systemic therapy is the standard treatment for unresectable colorectal cancer with liver metastasis (CRCLM). Transarterial chemoembolization with drug-eluting beads (DEB-TACE) is considered an effective treatment option for CRCLM. Few...
6.
Tsai H, Shi H, Chen Y, Huang C, Su W, Chang T, et al.
Am J Cancer Res
. 2023 Oct;
13(9):4039-4056.
PMID: 37818063
This study investigated the cost-effectiveness and quality of life (QoL) within 1 year of receiving mFOLOFX6 with or without a targeted drug (bevacizumab or ramucirumab) as second-line treatment among patients...
7.
Kuo Y, Chen Y, Yeh Y, Chang C, Li C, Cai T, et al.
Kaohsiung J Med Sci
. 2023 Aug;
39(11):1129-1134.
PMID: 37573495
In order to accurately monitor graft immunology, we have developed a method for performing intestine and abdominal wall transplantation heterotopically in miniature swine. The procedure consisted of simultaneous segmental terminal...
8.
Yeh Y, Tsai H, Chen Y, Su W, Chen P, Chang T, et al.
Oncol Res
. 2023 Jun;
30(2):65-76.
PMID: 37305327
The controversial outcomes in patients with metastatic colorectal cancer (mCRC) highlight the need for developing effective systemic neoadjuvant treatment strategies to improve clinical results. The optimal treatment cycles in patients...
9.
Chang T, Su W, Chen Y, Chen P, Li C, Yeh Y, et al.
Exp Ther Med
. 2023 Apr;
25(1):9.
PMID: 37081944
Neuroendocrine neoplasms (NENs) are a rare heterogeneous group of neoplasms that arise from neuroendocrine cells. Unknown-primary NENs (UP-NENs) are particularly challenging to diagnose and treat. Techniques such as immunohistochemical stains,...
10.
Yin T, Chen P, Yeh Y, Li C, Chen Y, Su W, et al.
Front Oncol
. 2023 Apr;
13:1099168.
PMID: 37064097
Background: Neoadjuvant chemoradiotherapy followed by total mesorectal excision is the standard treatment for patients with nonmetastatic locally advanced rectal cancer (LARC). However, for patients with LARC and synchronous metastasis, the...